BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8178358)

  • 1. Successful liver transplantation for isoniazid-induced hepatic failure--a case report.
    Hasagawa T; Reyes J; Nour B; Tzakis AG; Green M; Todo S; Starzl TE
    Transplantation; 1994 Apr; 57(8):1274-7. PubMed ID: 8178358
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoniazid toxicity in a 5-year-old boy.
    Science M; Ito S; Kitai I
    CMAJ; 2013 Jul; 185(10):894-6. PubMed ID: 23670154
    [No Abstract]   [Full Text] [Related]  

  • 3. Iatrogenic liver failure, transplantation, and prisoners.
    Spike J
    J Clin Ethics; 1997; 8(4):398-404. PubMed ID: 9503090
    [No Abstract]   [Full Text] [Related]  

  • 4. Isoniazid-related hepatic failure in children: a survey of liver transplantation centers.
    Wu SS; Chao CS; Vargas JH; Sharp HL; Martín MG; McDiarmid SV; Sinatra FR; Ament ME
    Transplantation; 2007 Jul; 84(2):173-9. PubMed ID: 17667808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for ecstasy-induced fulminant hepatic failure.
    De Carlis L; De Gasperi A; Slim AO; Giacomoni A; Corti A; Mazza E; Di Benedetto F; Lauterio A; Arcieri K; Maione G; Rondinara GF; Forti D
    Transplant Proc; 2001 Aug; 33(5):2743-4. PubMed ID: 11498145
    [No Abstract]   [Full Text] [Related]  

  • 6. IgG3 is the dominant subtype of anti-isoniazid antibodies in patients with isoniazid-induced liver failure.
    Metushi IG; Lee WM; Uetrecht J
    Chem Res Toxicol; 2014 May; 27(5):738-40. PubMed ID: 24786179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inadvertent diclofenac rechallenge from generic and non-generic prescribing, leading to liver transplantation for fulminant liver failure.
    Greaves RR; Agarwal A; Patch D; Davies SE; Sherman D; Reynolds N; Rolles K; Davidson BR; Burroughs AK
    Eur J Gastroenterol Hepatol; 2001 Jan; 13(1):71-3. PubMed ID: 11204815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation treating the patient with hepatic failure associated with sorafenib treatment: report of a case.
    Rao J; Feng M; Qian X; Li G; Wang X; Zhang F; Lu L
    Hepatogastroenterology; 2013 Sep; 60(126):1317-9. PubMed ID: 23933924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic decompensation associated with lamivudine: a case report and review of lamivudine-induced hepatotoxicity.
    Ormseth EJ; Holtzmuller KC; Goodman ZD; Colonna JO; Batty DS; Sjogren MH
    Am J Gastroenterol; 2001 May; 96(5):1619-22. PubMed ID: 11374710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrazine, cancer, the Internet, isoniazid, and the liver.
    Black M; Hussain H
    Ann Intern Med; 2000 Dec; 133(11):911-3. PubMed ID: 11103062
    [No Abstract]   [Full Text] [Related]  

  • 11. Minocycline and fulminant hepatic failure necessitating liver transplantation.
    Pohle T; Menzel J; Domschke W
    Am J Gastroenterol; 2000 Feb; 95(2):560-1. PubMed ID: 10685779
    [No Abstract]   [Full Text] [Related]  

  • 12. Accidental acetaminophen overdose results in liver transplant during second trimester of pregnancy: a case report.
    Franko KR; Mekeel KL; Woelkers D; Khanna A; Hemming AW
    Transplant Proc; 2013 Jun; 45(5):2063-5. PubMed ID: 23769109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecstasy-induced brain death and acute hepatocellular failure: multiorgan donor and liver transplantation.
    Caballero F; Lopez-Navidad A; Cotorruelo J; Txoperena G
    Transplantation; 2002 Aug; 74(4):532-7. PubMed ID: 12352914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful living donor liver transplantation of fulminant liver failure due to isoniazid prophylaxis.
    Çakır T; Ara C; Soyer HV; Koc S
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26106175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auxiliary heterotopic liver transplantation with portal vein arterialization for fulminant hepatic failure.
    Margarit C; Bilbao I; Charco R; Lázaro JL; Hidalgo E; Allende E; Murio E
    Liver Transpl; 2000 Nov; 6(6):805-9. PubMed ID: 11084073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of a patient suffering from severe acute potassium dichromate poisoning with liver transplantation.
    Stift A; Friedl J; Längle F; Berlakovich G; Steininger R; Mühlbacher F
    Transplantation; 2000 Jun; 69(11):2454-5. PubMed ID: 10868660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromfenac (Duract)-associated hepatic failure requiring liver transplantation.
    Hunter EB; Johnston PE; Tanner G; Pinson CW; Awad JA
    Am J Gastroenterol; 1999 Aug; 94(8):2299-301. PubMed ID: 10445569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case of fatal liver failure due to anti-tuberculous therapy].
    Harada Y; Kawakami K; Koyama K; Yamaryo T; Kimura Y
    Kekkaku; 2007 Sep; 82(9):705-9. PubMed ID: 17969987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The experimental study of the canine auxiliary partial liver transplantation for the liver failure].
    Huang JF; He XS; Xuan WH
    Zhonghua Wai Ke Za Zhi; 1994 Jun; 32(6):371-3. PubMed ID: 7842965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthotopic liver transplantation with poor neurologic outcome in valproate-associated liver failure: a need for critical risk-benefit appraisal in the use of valproate.
    Thomson MA; Lynch S; Strong R; Shepherd RW; Marsh W
    Transplant Proc; 2000 Feb; 32(1):200-3. PubMed ID: 10701024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.